Pamukcuoglu M, Baysal NA, Pepeler MS. The infection rate in new diagnosis and relapsed/refractory multiple myeloma patients who had bortezomib-based chemotherapy and relationship between development of infection and lymphocyte/monocyte ratio. Eur Res J. 2021;7(6):541-549. doi:10.18621/eurj.855510